Researchers discover brain mechanism responsible for sensation of nausea

Nausea is a common and distressing side effect of many drugs and treatments. Unlike vomiting, nausea is not well understood, but new research by University of Guelph scientists may soon change that.

Guelph PhD student Katharine Tuerke, neuroscience researcher Cheryl Limebeer and Prof. Linda Parker in the Department of Psychology believe they've found the mechanism in the brain that is responsible for the sensation of nausea - with the help of some "disgusted" rats.

Their study was published this week in Journal of Neuroscience.

"Although everyone has experienced nausea at some point, its neurobiology is poorly understood due to a lack of animal models," said Parker, who holds the Canada Research Chair in Behavioural Neuroscience.

"We know about vomiting. The vomiting reflex is very well characterized, but the experience of nausea is something that little is known about. How is it generated? Where is it generated?"

Although rats can't vomit, they do display a disgust reaction called gaping when re-exposed to a taste that made them feel nauseous in the past. Therefore, these gaping reactions in rats provide a model to understand brain mechanisms that produce nausea in humans.

Using this gaping model, the Guelph researchers, along with University of Toronto professor Paul Fletcher, discovered that serotonin release in the visceral insular cortex may be responsible for the sensation of nausea.

The insular cortex is a site of taste and illness input in the brain. Based on its cell structure and inputs, the insular cortex can be divided into two regions: the gustatory insular cortex and the visceral insular cortex. The gustatory insular cortex receives taste input and the visceral insular cortex receives input from regions of the gut that may produce the sensation of nausea.

Previous research has shown that the neurotransmitter serotonin is critical for the production of nausea. Indeed, classic anti-emetic drugs such as ondansetron that are used in chemotherapy treatment are drugs that block the action of a type of serotonin receptor, serotonin-3 receptors.

The researchers first demonstrated that depletion of serotonin in the entire insular cortex prevented the nausea-induced gaping reactions in rats, suggesting that serotonin activation in this region is necessary for the production of nausea.

Next they examined the effects of delivering drugs that either activate serotonin-3 receptors or block serotonin-3 receptors to specific regions of the insular cortex. In the visceral insular cortex, but not the gustatory insular cortex, activating serotonin caused nausea (produced gaping reactions) and blocking serotonin reduced nausea (eliminated gaping reactions).

These data suggest that the activation of the visceral insular cortex by serotonin may be responsible for the production of the elusive sensation of nausea, which is so difficult to treat.

Tuerke and Parker hope their work will lead to a better understanding of basic neural processes affected by prescribed drugs, with specific applications to controlling nausea and vomiting caused by cancer chemotherapy.

The research was supported by the Natural Sciences and Engineering Research Council of Canada.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI models can be trained to distinguish brain tumors from healthy tissue